Pharmaron Beijing (SHE:300759) completed the issuance of 2.18 billion yuan of zero-coupon convertible bonds settled in U.S. dollars, according to a Wednesday after-hours filing with the Shenzhen Stock Exchange.
The net conversion price per H share was HK$36.39, with net proceeds reaching $327.2 million.
Of the net proceeds, 70%, or $229 million, will fund expansion of its laboratory and contract development and manufacturing organization services, while 20%, or $65.4 million, will help repay debt, and 10%, or $32.7 million, will go to general corporate purposes.